Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism IL-32 modulators(interleukin 32 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Kidney Diseases | Preclinical | Canada | 17 Sep 2025 |





